Remidio
VUNO, Kakao Healthcare, Skylabs, and Remidio advance into Europe with partnership deals and regulatory approvals for AI in cardiac, chronic, and eye care.
        
        
          Also, Cureskin from India has launched an AI-powered hair analysis feature on its mobile application.
        
        
          Also, Remidio receives a CE mark for its AI tool for detecting referable diabetic retinopathy.
        
        
           
 
